Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-08

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Torrent Pharmaceuticals Limited's supplemental application for levetiracetam (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)